Conway Capital Management Inc. Makes New $2.25 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Conway Capital Management Inc. purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 4,569 shares of the medical equipment provider's stock, valued at approximately $2,245,000. Intuitive Surgical accounts for about 1.1% of Conway Capital Management Inc.'s investment portfolio, making the stock its 19th biggest holding.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical during the second quarter valued at about $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares in the last quarter. LGT Financial Advisors LLC boosted its stake in Intuitive Surgical by 415.4% during the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in Intuitive Surgical during the 2nd quarter worth approximately $37,000. Institutional investors own 83.64% of the company's stock.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of the business's stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 188 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,720,023. This trade represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 50,485 shares of company stock worth $26,128,102. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of ISRG traded down $0.77 during mid-day trading on Tuesday, hitting $538.09. The stock had a trading volume of 1,047,243 shares, compared to its average volume of 1,443,882. Intuitive Surgical, Inc. has a 52 week low of $309.80 and a 52 week high of $556.23. The business has a fifty day moving average price of $517.16 and a 200-day moving average price of $475.65. The firm has a market cap of $191.66 billion, a P/E ratio of 86.51, a PEG ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ISRG. Evercore ISI reaffirmed a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James raised their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research note on Monday, October 14th. JPMorgan Chase & Co. upped their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the stock an "overweight" rating in a research note on Friday, October 11th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Robert W. Baird boosted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $541.33.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.